title: Moraxella catarrhalis induces mast cell activation and nuclear factor kappa B-dependent cytokine synthesis.
abstract: Human mast cells are often found perivascularly and at mucosal sites and may play crucial roles in the inflammatory response. Recent studies have suggested a prominent role for mast cells in host defense. In this study, we analyzed the effects of a common airway pathogen, Moraxella catarrhalis and a commensal bacterium, Neiserria cinerea, on activation of human mast cells. Human mast cell leukemia cells (HMC-1) were activated with either phorbol myristate acetate (PMA) and calcium ionophore or with varying concentrations of heat-killed suspensions of bacteria. Supernatants were assayed for the cytokines interleukin-4 (IL-4), granulocyte macrophage colony stimulating factor (GM-CSF), IL-6, IL-8, IL-13 and monocyte chemotactic protein-1 (MCP-1). Nuclear proteins were isolated and assayed by electrophoretic mobility shift assay (EMSA) for nuclear factor kappaB (NF-kappaB) nuclear binding activity. In some experiments, NF-kappaB inhibitor, Bay-11 was added to determine functional significance. Both M. catarrhalis and N. cinerea induced mast cell activation and selective secretion of two key inflammatory cytokines, IL-6 and MCP-1. This was accompanied by NF-kappaB activation. Neither spun bacterial supernatants nor bacterial lipopolysaccharide induced cytokine secretion, suggesting need for direct bacterial contact with mast cells. Scanning electron microscopy revealed active aggregation of bacteria over mast cell surfaces. The NF-kappaB inhibitor, Bay-11, inhibited expression of MCP-1. These findings suggest the possibility of direct interactions between human mast cells and common bacteria and provide evidence for a novel role for human mast cells in innate immunity.
authors.affiliation: Department of Internal Medicine, East Tennessee State University, Johnson City, Tennessee 37614-1709, USA. krishnas@etsu.edu
authors.forename: G
authors.initials: G
authors.lastname: Krishnaswamy
authors.forename: R
authors.initials: R
authors.lastname: Martin
authors.forename: E
authors.initials: E
authors.lastname: Walker
authors.forename: C
authors.initials: C
authors.lastname: Li
authors.forename: F
authors.initials: F
authors.lastname: Hossler
authors.forename: K
authors.initials: K
authors.lastname: Hall
authors.forename: D S
authors.initials: DS
authors.lastname: Chi
mesh_terms: D045744:Cell Line, Tumor; D018932:Chemokine CCL2 / Q000096:biosynthesis / Q000378:metabolism; D016207:Cytokines / Q000096:biosynthesis* / Q000378:metabolism; D006801:Humans; D015850:Interleukin-6 / Q000096:biosynthesis / Q000378:metabolism; D007946:Leukemia, Mast-Cell / Q000276:immunology / Q000378:metabolism; D008407:Mast Cells / Q000276:immunology* / Q000378:metabolism* / Q000648:ultrastructure; D008855:Microscopy, Electron, Scanning; D001936:Moraxella catarrhalis / Q000276:immunology*; D016328:NF-kappa B / Q000502:physiology*; D042804:Neisseria cinerea / Q000276:immunology
chemical_list: D018932:Chemokine CCL2; D016207:Cytokines; D015850:Interleukin-6; D016328:NF-kappa B